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Although several efforts have been made in the search for genetic and epigenetic
patterns linked to diseases, a comprehensive explanation of the mechanisms underlying
pathological phenotypic plasticity is still far from being clarified. Oxidative stress and
inflammation are two of the major triggers of the epigenetic alterations occurring in
chronic pathologies, such as neurodegenerative diseases. In fact, over the last decade,
remarkable progress has been made to realize that chronic, low-grade inflammation is
one of the major risk factor underlying brain aging. Accumulated data strongly suggest
that phytochemicals from fruits, vegetables, herbs, and spices may exert relevant
immunomodulatory and/or anti-inflammatory activities in the context of brain aging.
Starting by the evidence that a common denominator of aging and chronic degenerative
diseases is represented by inflammation, and that several dietary phytochemicals are able
to potentially interfere with and regulate the normal function of cells, in particular neuronal
components, aim of this review is to summarize recent studies on neuroinflammaging
processes and proofs indicating that specific phytochemicals may act as positive
modulators of neuroinflammatory events. In addition, critical pathways involved in
mediating phytochemicals effects on neuroinflammaging were discussed, exploring the
real impact of these compounds in preserving brain health before the onset of symptoms
leading to inflammatory neurodegeneration and cognitive decline.
Keywords: antioxidants, Nfr2, resveratrol, sirtuins, curcumin
INTRODUCTION
In the last decades the increasing aging with consequent raise in chronic degenerative diseases
has led to an augmented investigation of the environmental factors involved in their origin and
progression.
Although several efforts have been made in the search for genetic and epigenetic patterns linked
to diseases, a comprehensive explanation of the mechanisms underlying pathological phenotypic
plasticity is still far from being clarified (Babenko et al., 2012). Epigenetic control of the gene
expression has been recognized as a key player in producing rapid adaptation to changing
environmental conditions both within a single lifespan as well as across multiple generations. These
mechanisms are particularly applied to the brain, which is capable of changing readily in response
to experience throughout a lifetime (Babenko et al., 2012).
Corbi et al. Dietary Phytochemicals in Human Neuroimmunoaging
Epigenetics is a branch of biology, which studies how changes
in gene expression occur without modifications in the DNA
sequence (Choudhuri, 2011). Such changes can be induced by
environmental factors, and can be highly stable, including those
resulting from genetic imprinting, or dynamic, including those
associated with memory (Lardenoije et al., 2015). Oxidative
stress and inflammation are two of the major triggers of the
epigenetic alterations occurring in chronic pathologies, such
as neurodegenerative diseases, especially in elderly population,
already characterized bymodifications of the normal homeostasis
of organs and systems.
Starting by the evidence that a common denominator of
aging and chronic degenerative diseases is represented by
inflammation, and that several dietary phytochemicals are
able to potentially interfere with and regulate the normal
function of cells (Scapagnini et al., 2014), in particular neuronal
components, aim of this review is to summarize recent
studies on the neuroinflammaging processes indicating that
specific phytochemicals may act as positive modulators of
neuroinflammatory events. In addition, pathways involved in
mediating phytochemicals effects on neuroinflammaging were
discussed, exploring the real impact of dietary phytochemicals in
preserving brain health before the onset of symptoms leading to
inflammatory neurodegeneration and cognitive decline.
FEATURES OF NEUROIMMUNOAGING
Over the last decade, remarkable progress has been made to
realize that chronic, low-grade inflammation is one of the major
risk factor underlying brain aging. During their life the cells
progressively impair the ability to defend themselves from stress
stimuli and, as a consequence, there is an accumulation of
oxidative damages in all cell constituents (Corbi et al., 2008;
Bianco et al., 2013; Lardenoije et al., 2015; Conti et al., 2015,
2016).
Growing evidence suggests that the brain and immune system
are intricately connected and crosstalk to maintain homeostasis.
Aging is associated with aberrant inflammatory responses in
human brains (Lu et al., 2004; Cribbs et al., 2012). Specifically,
basal levels of proinflammatory cytokines are elevated with aging
(Sierra et al., 2007), whereas anti-inflammatory mediators are
reduced (Ye and Johnson, 1999). In addition, other components
involved in innate immune responses, such as the complement
(C) pathway, the toll-like receptor (TLR) signaling, and the
inflammasome activation, are also upregulated as the brain ages
(Cribbs et al., 2012; Cho et al., 2015). In fact, during aging the
brain shows an imbalance between pro-and anti-inflammatory
cytokine levels (Figure 1).
It has been demonstrated both in humans and animal models
that aging is associated with decreased levels of interleukin
10 (IL10) (Ye and Johnson, 2001), and increased levels of
tumor necrosis factor alpha (TNFa) and IL1b in the nervous
system (Lukiw, 2004; Streit et al., 2004), as well as IL6 in
plasma (Ye and Johnson, 2001; Godbout and Johnson, 2004).
In addition, increased levels odtransforming growth factor b1
(TGFb1) mRNA, a key regulatory cytokine, has been observed
in the brain of aged mice and rats (Bye et al., 2001). At
the same time, several changes induced by an aged micro-
environment, such as increased systemic inflammation, increased
permeability of the blood-brain barrier (BBB), and degeneration
of neurons and other brain cells, could contribute to the
production of Radical Oxygen Species (ROS), thus generating
oxidative stress. It has been proposed that BBB permeability
increases in aged animals (Blau et al., 2012; Enciu et al.,
2013), facilitating perhaps infiltration by monocytes releasing
mitochondria-generated ROS. According to this hypothesis, an
age-related increase in the number of CD11bC and CD45 cells,
compatible with infiltrated monocytes, has been reported in the
brain of aged rats (Blau et al., 2012). Likewise, expression levels
of chemotactic molecules, such as interferon-inducible protein
10 (IIP10) and monocyte chemotactic protein-1 (MCP-1), are
increased in the hippocampal region (Blau et al., 2012; Von
Bernhardi et al., 2015).
With normal aging, the immunophenotype of microglia
is characterized by up-regulation of glial activation markers
including Major Histocompatibility Complex II (MHC II)
and CD11b, a finding reported in several species including
human post-mortem tissue, rodent, canine, and non-human
primates (Tafti et al., 1996; Sheffield and Berman, 1998).
This up-regulation of MHCII occurs also at the mRNA
level (Frank et al., 2006). Importantly, MHCII is expressed
at very low levels on microglia of younger animals under
basal conditions (Perry, 1998), providing a clear baseline to
detect aging-related changes in microglia immunophenotype.
Increased MHCII could result from aging-induced increases
in microglia number, or from increases in permicroglial cell
expression. Although only few studies are available, they
support the idea of increased permicroglial cell expression, and
therefore sensitization (Barrientos et al., 2015). Despite these
commonalities, the role of the immune system in aging and
neurodegenerative disease remains unclear (Lucin and Wyss-
Coray, 2009).
Microglia are the resident immune cells of the brain, endowed
with numerous receptors capable of detecting physiological
disturbances. When neurons are injured as a result of aging or
neurodegeneration, microglia become activated via the release of
adenosine triphosphate (ATP), neurotransmitters, growth factors
or cytokines, ion changes in the local environment, or loss of
inhibitor molecules displayed by healthy neurons (Hanisch and
Kettenmann, 2007).
The increase in expression of multiple TLRs in the
aging brain (Letiembre et al., 2007; Berchtold et al., 2008)
may generate a hypersensitive state of glia and neurons
and thus magnify potential injury. Stimulation of TLRs
induces a signaling cascade, culminating in the activation
of nuclear factor κB (NFκB) and subsequent transcriptional
activation of numerous proinflammatory genes, encoding
cytokines, chemokines, complement proteins, enzymes [such
as cyclooxygenase 2 (COX-2) and Inducible nitric oxide
synthase (iNOS)], adhesion molecules, and immune receptors
(Nguyen et al., 2004). Exactly how neuronal TLRs promote
neurodegeneration and the identity of their ligands is currently
unclear.
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FIGURE 1 | Phytochemicals effects on Neurooinflammaging. Neuroimmunoinflammaging is characterized by reduced SIRT1 and Nfr2 activity with consequent
increased NF-κB activation. The increased NF-κB activation, also trough Tool Like Receptors (TLR), induces in turn raised proinflammatory factors such as TNFa,
IL1b, IL6, iNOS. The disequilibrium between anti- (IL10) and pro-inflammatory molecules determines increased inflammation, and a vicious circle is established that
sustains neuroinflammaging. The phytochemicals (like curcumin, resveratrol, sulphurane, etc.) inducing increase in Nrf2 and SIRT1 activity could be able to inhibit the
NF-κB activation and then to break the vicious circle ending the progression of the brain aging.
However, aging results in a significant increase in glial
activation, complement factors, inflammatory mediators, and
brain atrophy (West et al., 1994; Streit et al., 2008). Microarrays
of aged human and mouse brains showed that genes related
to cellular stress and inflammation increase with age while
genes related to synaptic function/transport, growth factors, and
trophic support decrease (Lee et al., 2000). These changes suggest
that neurons encounter increased challenges with age but receive
reduced support. Neurogenesis also decreases with age, possibly
as a result of factors secreted by activated microglia (i.e., IL-
6). To date, it is unclear the reason of increased inflammation
during aging. However, genetic studies suggest an important
role of Deoxyribonucleic Acid (DNA), because DNA bases are
particularly vulnerable to oxidative stress damage leading to
important inflammatory alterations (Bianco et al., 2013). Also
unclear is to what extent aging affects the responsiveness of
microglia or their potential to contribute to neuronal loss.
Despite morphological and phenotypic changes that indicate
microglial activation, it has been proposed that microglia
may actually become dysfunctional and enter a senescent
state with age (Streit et al., 2008). Such a state may cause
microglia to secrete diminished levels of neurotrophic factors and
downregulate phagocytic function. This phenomenon, associated
with increased secretion of inflammatory mediators, may lead to
neuronal loss and inefficient clearance of toxic protein aggregates
in neurodegenerative disease (Lucin and Wyss-Coray, 2009).
Finally, it should be also highlighted that mounting evidence
indicates that epigenetic mechanisms play a significant role in
shaping environmental influences on brain and behavior (Kosik
et al., 2012).
Nrf2 AND SIRTUINS PATHWAY INVOLVED
IN NEUROIMMUNOAGING
Although definitive mechanisms are still to be elucidated, the
pro-inflammatory phenotype of senescent cells, coupled with the
up-regulation of the inflammatory response with increasing age,
has been found to play a role in the initiation and progression of
age-related diseases such as Alzheimer’s disease (Cevenini et al.,
2013; Patel et al., 2015).
A large body of evidence has highlighted a role of class
III histone deacetylases, named sirtuins, in neurodegenerative
processes (Kim et al., 2007; Vang et al., 2011; Baur et al., 2012).
Sirtuin 1 (SIRT1), the main characterized molecule of sirtuins
family, regulates immune responses via NF-κB signaling and in
this way also controls the ROS production (Salminen et al., 2013).
The NF-κB signaling is a crucial pathway of immune
defense system and an inducer of inflammatory responses
(Vallabhapurapu and Karin, 2009). The NF-κB system is involved
in many housekeeping and survival functions during cellular
stress e.g., by controlling apoptosis, proliferation, and energy
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metabolism (Karin and Lin, 2002; Perkins, 2007; Johnson and
Perkins, 2012). Both SIRT1 and oxidative stress are known to
be able to regulate NF-κB signaling and are crucially involved
in the maintenance of cellular homeostasis (Yeung et al., 2004;
Morgan and Liu, 2011). Moreover, several studies demonstrated
that NF-κB signaling is activated during aging (Helenius et al.,
2001; Csiszar et al., 2008).
The crosstalk between oxidative stress and inflammation is
a complex process and there are studies reporting that ROS
can stimulate inflammation via the activation of inflammasomes
and the production of IL-1β and IL-18 cytokines, which
subsequently trigger inflammatory responses (Kitazawa et al.,
2005; Heneka and O’Banion, 2007; Salminen et al., 2013).
Many studies have also demonstrated that SIRT1 is a potent
intracellular inhibitor of oxidative stress and inflammatory
responses (Rajendran et al., 2011; Salminen et al., 2011). In
particular, SIRT1 is a powerful inhibitor of NF-κB signaling
and thus it suppresses inflammation (Yeung et al., 2004;
Salminen et al., 2008a). Many downstream targets of SIRT1
also repress inflammatory responses, e.g., AMP-activated protein
kinase (AMPK) (Salminen et al., 2011) and Forkhead box O
(FoxO) factors (Lin et al., 2004), by inhibiting the NF-κB
signaling. Yeung et al. (2004) revealed that SIRT1 performs its
antinflammatory activity by deacetylating the Lys310 residue
of v-rel avian reticuloendotheliosis viral oncogene homolog
A/p65 (RelA/p65) component, thus inhibiting the transactivation
capacity of the NF-κB complex. Recently Cho et al. (2015)
showed that SIRT1 levels in microglia exhibit an age-dependent
decline, and microglial SIRT1 deficiency leads to cognitive
decline in normal aging. The authors suggested that aging-
induced SIRT1 deficiency in microglia could initiate epigenetic
alterations on IL-1beta, leading to its enhanced expression that
is associated with impairments in memory and related cognitive
decline.
Moreover, there is a growing body of evidence suggesting
that activation of SIRT1 and other sirtuins can protect neurons
in experimental models of neurodegenerative disorders (Duan,
2013). In particular Min et al. (2010) demonstrated that tau
protein, that stabilizes microtubules, is acetylated and tau
acetylation prevents degradation of phosphorylated tau (p-
tau). Hyperphosphorylation of the tau protein can result in
the self-assembly of tangles of paired helical filaments and
straight filaments, which are involved in the pathogenesis of
Alzheimer’s disease, and other tauopathies (Alonso et al., 2001).
Deleting SIRT1 enhanced levels of acetylated-tau and pathogenic
forms of p-tau, probably by blocking proteasome-mediated
degradation. These results indicate that SIRT1 can prevent
the formation of neurofibrillary tangles (Min et al., 2010; Lee
et al., 2014). In primary cortical cultures, overexpression of
SIRT1 in microglia protected against amyloid beta toxicity,
most likely by inhibiting NF-κB signaling (Chen et al.,
2005). SIRT1 could also protect against cellular senescence by
inactivating NF-κB (Rovillain et al., 2011; Tilstra et al., 2012)
or deacetylating the FOXO3 transcription factor (Yao et al.,
2012). In addition, SIRT1 could also enhance the T helper 2
(Th2) lymphocytes responses in dendritic cells (Legutko et al.,
2011).
In the Wallerian degeneration slow (Wlds) mouse model,
SIRT1 activation protects axons against neuronal injury (Dali-
Youcef et al., 2007). Decreasing SIRT1 activity reduces the
axonal protection originally observed, whereas SIRT1 activation
by resveratrol decreases the axonal degeneration after neuronal
injury (Suzuki and Koike, 2007). This suggests that the
neuroprotection in the Wild mouse model is achieved by
increasing the neuronal nicotinamide adenine dinucleotide
(NAD+) reserve and/or SIRT1 activity (Dali-Youcef et al.,
2007). Also the inhibition of sirtuin 2 (SIRT2) rescued a-
synuclein toxicity and modified inclusion morphology in a
cellular model of Parkinson’s disease and genetic inhibition of
SIRT2 via small interfering RNA similarly rescued a-synuclein
toxicity (Outeiro et al., 2007). Furthermore, the inhibitors
protected against dopaminergic cell death both in vitro and in
a Drosophila model of Parkinson’s disease, suggesting another
link between neurodegeneration and aging (Outeiro et al., 2007).
In addition, SIRT1 activation significantly decreases neuronal
cell death induced by amyloid-beta peptides through inhibition
of NF-κB signaling (Dali-Youcef et al., 2007). In particular
SIRT1 deacetylates retinoic acid receptor beta (RARb) and
activates a disintegrin and metalloprotease domain (ADAM) 10
transcription, leading to upregulated Amyloid Precursor Protein
(APP) processing by a-secretase, resulting in reduced production
of Amyloid beta (Aβ) peptide (Donmez et al., 2010). Thanks
to these evidences, SIRT1, as well as the other sirtuins, is
now considered a promising therapeutic option for neurological
syndromes, such as Alzheimer, Parkinson, and Huntington’s
disease (Donmez et al., 2010; Jeong et al., 2012), and in general
for the control and progression of the neuroimmunoaging.
Another key molecule involved in neuroimmunoaging is
represented by Nuclear factor (erythroid-derived 2)-like 2 (Nrf2).
Emerging evidence suggests that Nrf2 may play an important
role in the regulation of brain inflammation, and some studies
have suggested that Nrf2 has an antagonistic effect with the NF-
κB pathway, which is considered a hallmark of inflammation
(Liu et al., 2008; Djordjevic et al., 2015). Nrf2 is a member
of the Cap‘n’Collar family of transcription factors that bind
to nuclear factor erythroid derived 2 (NF-E2) binding sites
(GCTGAGTCA) that are essential for the regulation of erythroid
specific genes. Nrf2 is expressed in a wide range of tissues, many
of which are sites of expression for phase 2 detoxification genes
(Dinkova-Kostova et al., 2002) and targeted for ubiquitination
and proteasomal degradation via binding to a cytosolic repressor
protein, Kelch-like ECH associated protein 1 (Keap1) (McMahon
et al., 2006). The principle of the Nrf2 system is to keep Nrf2
protein low under normal conditions with the possibility of rapid
induction in case of a sudden increase in oxidation status in the
cell. This is achieved by constitutive synthesis and degradation
of Nrf2 with the possibility of rapid redirection of Nrf2 to the
nucleus. (Sandberg et al., 2014). There is now overwhelming
amount of experimental evidence that Nrf2 serves as a master
regulator of the antioxidants involved in cellular defenses against
various electrophiles and oxidants (Kobayashi and Yamamoto,
2006; Calabrese et al., 2008). Indeed new findings connect Nrf2
also to expression of other types of protective proteins such
as brain derived neurotrophic factor (BDNF) (Sakata et al.,
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2012), the anti-apoptotic B-cell lymphoma 2 (BCL-2) (Niture
and Jaiswal, 2012), the anti-inflammatory interleukin (IL)-10, the
mitochondrial transcription (co)-factors NRF-1 and peroxisome
proliferator-activated receptor gamma coactivator 1-alpha (PGC-
1α) (Piantadosi et al., 2011).
The relation betweenNrf2 andNF-κB is not well characterized
but the identification of NF-κB binding sites in the promoter
region of the Nrf2 gene suggests cross talk between these two
regulators of inflammatory processes (Nair et al., 2008). The NF-
κB subunit p65 has been shown to function as a negative regulator
of Nrf2 activation either by depriving cAMP response element-
binding protein (CBP) from NRF2 or by recruitment of histone
deacetylase 3 (HDAC3), causing local histone hypoacetylation
and down-regulation of Nrf2-antioxidant responsive element
(Nrf2-ARE) signaling (Liu et al., 2008). Yu et al. (2011) have
shown that p65 decreased Nrf2 binding to its cognate DNA
sequences and enhanced Nrf2 ubiquitination, then providing
direct evidence that the interaction of nuclear factor p65 with
Keap1 is critical for NF-κB repressing Nrf2-ARE pathway.
Moreover, the N-terminal region of p65 was necessary for both
the interaction with Keap1 and its transcriptional suppression
activity, and nuclear translocation of Keap1 was augmented by
p65. The authors concluded that taken together, these findings
suggest that NF-κB signaling inhibits Nrf2-ARE pathway through
the interaction of p65 and Keap1 (Yu et al., 2011). Further,
activation of NRF2 in response to lipopolysaccharide (LPS) has
been suggested to be dependent on the key innate immunity-
regulating adaptor protein Myeloid differentiation primary
response gene 88 (MyD88) (Kim et al., 2011). In particular Kim
et al. (2011) demonstrated that treatment of macrophages with
LPS activates Nrf2. Interestingly, the authors found that Nrf2 is
activated in aMyD88 dependent fashionwithout the involvement
of ROS. These results suggest the possibility that Nrf2 activated
by inflammatory stimuli can be a mechanism that contributes to
decreasing excessive inflammatory response (Kim et al., 2011). A
study demonstrated that Nrf2 knockoutmice were hypersensitive
to the neuroinflammation induced by LPS, indicative of an
increase in microglial cells, and in the inflammation markers
iNOS, IL-6, and TNF-α, compared with the hippocampi of wild-
type littermates (Innamorato et al., 2008). Activation of NRF2
could also be achieved via the increase in peripheral IGF-1 that
enters the brain after exercise (Cotman et al., 2007; Sandberg
et al., 2014).
Recently Rojo et al. (2010) showed that Nrf2-deficient mice
exhibited more astrogliosis and microgliosis. Inflammation
markers characteristic of classical microglial activation, COX-2,
iNOS, IL-6, and TNF-αwere also increased and, at the same time,
anti-inflammatory markers attributable to alternative microglial
activation, such as FIZZ-1 and IL-4 were decreased. These results
were confirmed in microglial cultures, further demonstrating a
role of Nrf2 in tuning balance between classical and alternative
microglial activation (Rojo et al., 2010).
Aging drives a long-lasting sub-ventricular zone impairment
at least in part via reduced Nrf2-mediated tolerance to
inflammation and oxidative stress associated with dysfunctional
astrocyte–microglial dialogue, in turn interrupting key molecular
signaling mechanisms finely regulating sub-ventricular cell
homeostasis (L’Episcopo et al., 2013). In particular, when
“primed” microglia of aged mice become hyperactivated upon
a second hit, the generation of highly toxic mediators in the
face of impaired antioxidant self-protective neuroprogenitor cell
response dramatically inhibits neurogenesis, suggesting that glial
age is of critical importance in directing promotion vs. inhibition
of neurogenesis. Interestingly, with age, the exaggerated
microglial activation can impair an astrocyte’s ability to express
critical antioxidant, anti-inflammatory, and neurogenic factors,
thereby resulting in an overall reduction of glial proneurogenic
capacities (L’Episcopo et al., 2013). These processes may
disrupt the cross talk between two pivotal pathways in sub-
ventricular zone, the NrF2/ Fosfoinositide 3-chinasi/Protein
kinase B (Nrf2/PI3-K/Akt) and the Drosophila melanogaster
wingless gene/receptor Frizzled/β-catenin (Wnt/Fzd/β-catenin)
signaling cascades, involved in cell survival, proliferation,
and/or differentiation. The manipulation of these age-related
Nrf2 pathways at middle age is associated with significant
Dopaminergic neuroprotection (L’Episcopo et al., 2013). A
study also demonstrated that direct intrahippocampal gene
delivery of Nrf2, by a lentiviral vector, results in a reduction in
spatial learning deficits in aged mice (Kanninen et al., 2009).
In particular memory improvement in the mice after Nrf2
transduction shifts the balance between soluble and insoluble
Aβ toward an insoluble Aβ pool without concomitant change
in total brain Aβ burden. Nrf2 gene transfer was associated
with reduction in astrocytic but not microglial activation and
induction of Nrf2 target gene Heme Oxygenase 1 (HO-1),
indicating overall activation of the Nrf2-ARE pathway in
hippocampal neurons 6 months after injection (Kanninen et al.,
2009). Based on this body of emerging evidence it seems that in
many cases the beneficial effects of low doses of phytochemicals
rely on their ability to activate the Nrf2/ARE and sirtuins
pathways.
MECHANISMS OF DIETARY
PHYTOCHEMICALS IN
NEUROIMMUNOAGING
Dietary phytochemicals include a large group of no-nutrients
compounds from a wide range of plant-derived foods and
chemical classes. Several plant-based extracts and chemicals are
supposed to have beneficial effects on human brain function.
The potential effect of these molecules is linked to the
common ancestry, which has provided some phytochemicals of
conserved cellular processes, including the similarities in most
pathways for synthesis and breakdown of proteins, nucleic acids,
carbohydrates, and lipids (Kennedy and Wightman, 2011). In
fact, some molecules that function as neurochemicals within the
mammalian central nervous system (CNS) are ubiquitous across
all eukaryotes (Kawashima et al., 2007).
At a molecular level, signaling molecules and pathways
are preserved in both plants and animals (Kushiro et al.,
2003). For instance, multiple aspects of cellular and redox
signaling are conserved (Dalle-Donne et al., 2009), including
similar gene expression in response to cellular stressors, which
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are regulated by common transcription factors (Scandalios,
2005).
The basis for the use of polyphenol-rich nutritional
supplements as a modulator of age-related cognitive decline is
the age-related increase in oxidative stress (Morris et al., 2006;
Craft et al., 2012) and low-grade inflammation.
Often the beneficial effects of phytochemicals are supposed
to be due to their intrinsic antioxidant and antinflammatory
properties (Murugaiyah and Mattson, 2015).
At low doses, phytochemicals have beneficial or stimulatory
effects on animal cells, whereas in high amounts can be toxic.
This is an example of “hormesis” (Mattson, 2008; Lee et al., 2014).
Hormetic phytochemicals such as resveratrol, sulforaphane,
curcumin, catechins, allicin, and hypericin are reported to
activate adaptive stress response signaling pathways that increase
cellular resistance to injury and disease (Mattson and Cheng,
2006).
Also neuroactive phytochemicals present in commonly
consumed fruits, vegetables, and nuts are generally well tolerated
(Wöll et al., 2013; Lee et al., 2014). These phytochemicals are
hormetic substances because they can be toxic in high amounts,
but are beneficial in the lower amounts usually consumed
(Mattson, 2015). In this context, although controversial data
are available on the capacity of these compounds to cross the
BBB and bioavailability continues to be highlighted as a major
concern, hormetic dose-response model has important biological
and clinical implications, including activation of neuroprotective
stress response pathways at low concentrations (Schaffer and
Halliwell, 2012; Davinelli et al., 2016).
Their effects are represented as a biphasic dose–response
curve, with the first phase being a positive/beneficial effect
and the second phase with a progressively negative/toxic effect
(Calabrese et al., 2007; Mattson et al., 2007).
Recent findings suggest that adaptive cellular stress responses
to phytochemicals are mediated via some of the same pathways
that mediate responses to energy restriction and exercise
(Mattson, 2012; Milisav et al., 2012). Commonly consumed
phytochemicals are able to induce mild stress in neural cells,
enhancing the ability of nervous system to cope with stress,
and then promoting optimal function and longevity of the
nervous system. As with exercise and energy restriction, intake of
neurohormetic phytochemicals typically occurs on intermittent
basis, which provides a “recovery period” that allows cells to
repair and growth (Mattson, 2015). Examples include pathways
that signal via Nrf2, SIRT1, and AMPK (Menendez et al., 2013;
Misra et al., 2013). Activation of one or more of these signaling
pathways that evolved to defend cells against potentially toxic
phytochemicals appears to be a major reason why ingestion of
these substances can protect neurons against injury and disease
(Calabrese et al., 2008; Murugaiyah and Mattson, 2015).
SOME PHYTOCHEMICALS POTENTIALLY
USEFUL IN NEUROPROTECTION
Several studies indicate that antioxidants, e.g., dietary
polyphenols, can inhibit inflammation, and in particular
the terpenoids, are able to inhibit NF-κB signaling and thus
repress inflammation (Rahman et al., 2006; Salminen et al.,
2008b).
In this context, there are many mutual interactions and a
delicate balance exists between SIRT1 and ROS signaling which
provoke context-dependent responses to autophagic flux and
inflammation (Salminen et al., 2013).
Phytochemicals like curcumin, resveratrol, terpenoids,
epigallocatechin-3-gallate (EGCG), and isothiocyanates share
common properties and play an important role to activate
the phase II detoxifying and antioxidant enzymes like HO-1,
glutathione peroxidase (GSH-Px), and glutathione-S-transferase
(GST) by targeting the common transcription factor Nrf2 (Liby
et al., 2007; Tosetti et al., 2009).
Recent findings suggest that several phytochemicals exhibit
biphasic dose responses on cells with low doses activating
signaling pathways that result in increased expression of genes
encoding survival proteins, as in the case of the Keap1/Nrf2/ARE
pathway activated by curcumin and NAD/NADH-sirtuin-1
activated by resveratrol.
To underline the role of the dietetic components in modifying
cellular mechanisms, recently Morrison et al. (2010) showed as
in 20-month old male mice fed either ‘western diet’ (41% fat),
very high fat lard diet (60% fat), or corresponding control diets
for 16 weeks, only the high fat lard diet increased age-related
oxidative damage and impaired retention in the behavioral test.
This selective increase in oxidative damage and cognitive decline
was also associated with a decline in Nrf2 levels and activity,
suggesting a potential role for decreased antioxidant response.
Then the authors suggested that impaired Nrf2 signaling and
increased cerebral oxidative stress as mechanisms underlying
High Fat Diet-induced declines in cognitive performance in the
aged brain (Morrison et al., 2010).
Ferulic Acid
Ferulic acid (FA) is commonly found in fruits and vegetables
such as tomatoes, sweet corn, and rice (Srinivasan et al., 2007).
It has been reported that this compound decreases the levels
of inflammatory mediators (prostaglandin E2 and TNF-α) (Ou
et al., 2003), and iNOS expression and function (Tetsuka et al.,
1996). In vivo, long-term administration of FA effectively protects
against Aβ toxicity by inhibiting microglial activation (Kim et al.,
2004).
Kanaski et al. (2002) reported that FA protects against free
radical mediated changes in the conformation of synaptosomal
membrane proteins. The long-term administration of FA at
a dose of 300 µM effectively protects against Aβ toxicity
by inhibiting microglial activation in vivo (Kim et al.,
2004). Moreover, Sultana et al. (2005) showed that also
at lower doses of 10–50 µM significantly protects against
Aβ toxicity by modulating oxidative stress directly and by
inducing protecting genes in hippocampal cultures, also exerting
neuroprotective effects by up-regulation of protective enzymes,
such as Hemeoxygenase-1 (HO-1) and heat shock protein
70 (Hsp70) (Scapagnini et al., 2004; Srinivasan et al., 2007)
then suggesting a control by Nrf2 and sirtuins on the FA
effects. More recently Mori et al. (2013) demonstrated that also
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orally administration of FA for 6 months improved behavioral
impairment, mitigated cerebral amyloidosis, and inhibited APP
metabolism by reducing β-site APP cleaving enzyme 1 (BACE1)
expression and β-secretase activity in an accelerated mouse
model of cerebral amyloidosis. Supporting results from cultured
mutant human APP-overexpressing murine neuron-like cells
revealed FA dose-dependent reduction of various Aβ species
and inhibition of β-secretase cleavage. FA also ameliorated
neuroinflammation in including β-amyloid plaque-associated
gliosis and expression of the proinflammatory cytokines, TNF-
α, and IL-1β. Lastly, mRNA expression of three oxidative stress
markers [superoxide dismutase 1 (SOD1), catalase (CAT), and
GSH-Px 1] was decreased in FA-treated mice, providing support
for long-term FA dietary supplementation as a therapeutic
strategy (Mori et al., 2013).
Green Tea
The consumption of green tea has recently attracted much
attention in the occidental culture because of its beneficial
effects, such as protection of dopaminergic neurons from damage
induced by 6-hydroxydopamine in a rat model of Parkinson’s
disease (Guo et al., 2007); reduction of mutant huntingtin
misfolding and neurotoxicity in Huntington’s disease models
(Ehrnhoefer et al., 2006); direct protection of neurons against Aβ
toxicity (Bastianetto et al., 2000); protection against Aβ-induced
cognitive impairment in a rat model relevant to Alzheimer’s
disease (Haque et al., 2008). Moreover, a study by Wu et al.
(2006) reports that one of its component, epigallocatechin gallate
(EGCG), up-regulates HO-1 expression by activation of the Nrf2-
ARE pathway in endothelial cell, conferring resistance against
Hydrogen peroxide (H2O2) induced cell death, suggesting a
hormetic mechanism of action (Wu et al., 2006).
It has been demonstrated that EGCG selectively protects
cultured rat cerebellar granule neurons from oxidative stress
(Schroeder et al., 2009).
More recently Obregon et al. have confirmed that oral
administration of EGCG promotes cleavage of APP into α-CTF
and soluble APP-α (Obregon et al., 2006). These cleavage events
are associated with elevated α-secretase cleavage activity and
are also positively correlated with activation of ADAM10, a key
candidate α-secretase (Rezai-Zadeh et al., 2008), then suggesting
a role of sirtuins in mediating EGCG effects (Donmez et al., 2010;
Jeong et al., 2012).
Blueberry and Strawberry
Evidences showed that plant extracts, frommulberry, strawberry,
and blueberry, contain antioxidants, which are able to induce the
antioxidant defense system and improve memory deterioration
in aging animals (Shih et al., 2010).
Supplementation of the diet of 19 month-old rats with
strawberry, blueberry or spinach extracts for 8 weeks resulted
in the reversal of age-related deficits in several neuronal
and behavioral parameters (Joseph et al., 1999). Blueberry
supplementation prevented learning and memory deficits in
a mouse model of Alzheimer’s disease (Joseph et al., 2003).
In addition, dietary supplementation with blueberry extract
increased the survival of dopamine-producing neurons in
a model relevant to Parkinson’s disease therapy (McGuire
et al., 2006). Moreover, blueberries and strawberries counter
the deleterious effects of irradiation by reducing oxidative
stress and inflammation, thereby improving neuronal
signaling, preventing the accumulation of disease-related
proteins such as tau in the hippocampus of irradiated rats
(Poulose et al., 2014).
Indeed Andres-Lacueva et al. (2005) examined whether
different classes of polyphenols could be found in brain areas
associated with cognitive performance following blueberry (BB)
supplementation. Thus, 19 months old F344 rats were fed a
control or 2% BB diet for 8–10 weeks and tested in the Morris
Water Maze (MWM), a measure of spatial learning and memory.
Several anthocyanins were found in the cerebellum, cortex,
hippocampus, or striatum of the BB supplemented rats, but
not the controls. Correlational analyses revealed a relationship
between MWM performance in BB rats and the total number
of anthocyanin compounds found in the cortex, suggesting that
these compounds may deliver their antioxidant and signaling
modifying capabilities centrally.
To support and clarify the antioxidants effects of this
compound recently Çoban et al. (2015) investigated the
consequence of whole fresh BB treatment at different
percentages on oxidative stress in age-related brain damage
model. The study showed that BB treatments, especially BB
at higher percentage reduced malondialdehyde and Protein C
levels and acetylcholinesterase activity and elevated glutathione
(GSH) levels and GSH-Px activity, diminishing apoptosis and
ameliorating histopathological findings in the brain of rats
treated with D-galactose (GAL). The authors concluded that
BB partially prevented the shift toward an imbalanced pro-
oxidative status and apoptosis together with histopathological
amelioration by acting as an antioxidant (radical scavenger) itself
in GAL-treated rats (Çoban et al., 2015).
It has been reported that long-term treatment with blueberry
has also a neuroprotective effect in attenuating cerebral
ischemia/reperfusion (I/R) injury. Zhou et al. (2015) showed that
24 h after I/R, pterostilbene (a major component of blueberry)
dose-dependently improved neurological function, reduced
brain infarct volume, and alleviated brain oedema. The most
effective dose was 10 mg/kg; the therapeutic time window was
within 1 h after I/R and treatment immediately after reperfusion
showed the best protective effect. The protective effect was
further confirmed by the results that post-ischemic treatment
with pterostilbene (10 mg/kg) significantly improved motor
function, alleviated BBB disruption, increased neurons survival
and reduced cell apoptosis in cortical penumbra after cerebral
I/R. The authors also found that pterostilbene (10 mg/kg)
significantly reversed the increased content of malondialdehyde
and the decreased activity of superoxide dismutase in the
ipsilateral hemisphere, with decrease of the oxidative stress
markers 4-hydroxynonenal and 8-hydroxyguanosine positive
cells in the cortical penumbra. Then pterostilbene dose- and
time-dependently exerts a neuroprotective effect against acute
cerebral I/R injury (Zhou et al., 2015) and its antioxidant
action is mediated by the increased expression of Nrf2
(Saw et al., 2014).
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Curcumin
Curcumin, the principal curcuminoid and the most active
component in turmeric, is a biologically active phytochemical.
Several beneficial effects of curcumin for the nervous system
have been reported. In an animal model of stroke curcumin
treatment protected neurons against ischemic cell death and
ameliorated behavioral deficits (Wang et al., 2005). A hormetic
mechanism of action of curcumin is suggested from studies
showing that levels of expression of the stress response protein
HO-1 were increased in cultured hippocampal neurons treated
with curcumin (Scapagnini et al., 2006). Moreover, curcumin
has been shown to reverse chronic stress-induced impairment
of hippocampal neurogenesis and increase expression of BDNF
in an animal model of depression (Xu et al., 2007). At non-toxic
concentrations, curcumin induces HO-1 expression by activating
the Nrf2/ARE pathway both in vitro (Pae et al., 2007) and in vivo
(Farombi et al., 2008).
Several studies also showed that curcumin interacts with
NF-κB, and through this interaction exerts protective function
also in the regulation of T-cell-mediated immunity (Kou et al.,
2013). Recently González-Reyes et al. (2013) identified curcumin
as a neuroprotector against hemin-induced damage in primary
cultures of cerebellar granule neurons of rats. Hemin, the
oxidized form of heme, is a highly reactive compound that
induces cellular injury. Pre-treatment of the neurons with
5–30µM curcumin increased by 2.3–4.9-fold HO-1 expression
and by 5.6–14.3-fold GSH levels. Moreover, 15µM curcumin
attenuated by 55% the increase in ROS production, by 94% the
reduction of GSH/glutathione disulfide ratio, and by 49% the
cell death induced by hemin. Furthermore, it was found that
curcumin was capable of Nrf2 translocation into the nucleus,
suggesting that the pre-treatment with curcumin induces Nrf2
and an antioxidant response that may play an important role in
the protective effect of this antioxidant against hemin-induced
neuronal death (González-Reyes et al., 2013).
In rodents and human cells, curcumin-induced HO-1
overexpression was correlated with production of mitochondrial
ROS, activation of transcription factors Nrf2 and NF-κB,
induction of Mitogen-activated protein kinase (MAPK) p38 and
inhibition of phosphatase activity (Andreadi et al., 2006; McNally
et al., 2007). Moreover, curcumin is an activator of Nrf2 (Moi
et al., 1994) by changing specific highly reactive cysteine residues
of Keap1 (Dinkova-Kostova et al., 2002, 2005), with consequent
lost ability of Keap1 to target Nrf2 for degradation, which
then undergoes nuclear translocation. By using an Alzheimer
transgenic mouse model (Tg2576), Lim et al. (2001) shown
that dietary curcumin in vitro, inhibited aggregation as well
as disaggregated fibrillary Amyloid beta (Aβ). In vivo studies
showed that curcumin injected peripherally into aged mice
crossed the BBB and directly bound small β-amyloid species to
block aggregation and fibril formation in vitro and in vivo. These
data suggest that low dose curcumin effectively disaggregates Aβ
as well as prevents fibril and oligomer formation, supporting the
rationale for curcumin use in clinical trials (Lim et al., 2001).
More recently, Garcia-Alloza et al. (2007) in transgenic
APPswe/PS1dE9 mice demonstrated that curcumin, given
intravenously for 7 days, crosses the BBB, binds to β-amyloid
deposits in the brain and accelerates their rate of clearance
(Garcia-Alloza et al., 2007).
Curcumin was also demonstrated to exert a neuroprotective
effect in rats who underwent ischemia/reperfusion injury and
this effect has been related to the direct scavenger effect of
curcumin as well as to a curcumin-induced interference with the
apoptotic machinery, increase in antioxidant molecules (GSH)
and enzymes such as CAT and SOD (Al-Omar et al., 2006;
Calabrese et al., 2008).
Sulforaphane
Sulforaphane (SFN), a phytochemical present in high amounts
in cruciferous vegetables such as broccoli, is known to activate
the Nrf2-ARE stress response pathway in rodent brains and
microvasculature and by this to reduce brain damages in a
traumatic brain injury model (Zhao et al., 2007). Sulforaphane
has been reported to protect cultured neurons against oxidative
stress (Kraft et al., 2004), and dopaminergic neurons against
mitochondrial toxins (Han et al., 2007; Son et al., 2008).
This compound administration initiated at 1 h post-cortical
impact injury has been shown to improve cognitive function, in
particular spatial learning and memory, and to reduce working
memory dysfunction (Dash et al., 2009).
In a model of neonatal hypoxia-ischemia, pretreatment
with SFN increased the expression of Nrf2 and HO-1 in the
mouse brain and reduced infarct ratio (Ping et al., 2010).
Numerous other non-nutrients contained in food and plants
have been ascribed to the list of Nrf2 activators, and among
these several food-contained antioxidant polyphenols. One of
the most important aspects of current polyphenol research
is the focus on the neuroprotective capacity endowed by
these molecules that seems to be due mostly to their ability
to activate different defensive molecular pathways, instead to
involve just their intrinsic antioxidant properties (Scapagnini
et al., 2011).
In this regard, it has been recently demonstrated the critical
role of Nrf2/HO-1 activation by some of these neuroprotective
compounds, providing insight into the possible therapeutic
significance of a closely related group of polyphenols against
neurodegenerative disorders and cognitive decline (Scapagnini
et al., 2011).
Resveratrol
Neuroprotective effects of resveratrol have been reported by
several different studies, in particular on beta-amyloid-induced
oxidative cell death (Jang and Surh, 2003) and against several
different insults on dopaminergic neurons of midbrain slice
cultures (Okawara et al., 2007).
In particular in cultured rat pheochromocytoma (PC12)
cells Resveratrol attenuated Aβ-induced cytotoxicity, apoptotic
features, and intracellular ROS accumulation. Moreover, Aβ
transiently induced activation of NF-κB was suppressed by
resveratrol pretreatment (Jang and Surh, 2003) suggesting a key
role of the NF-κB inflammatory pathway in the Aβ deposition
and a possible therapeutic function of resveratrol in mediating
neuroprotection.
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Resveratrol protects cortical neurons from oxidative stress-
induced injury (Zhuang et al., 2003), and suppress alcohol-
induced cognitive deficits and neuronal apoptosis (Tiwari and
Chopra, 2013). In addition, resveratrol has been found to reduce
the production of IL-1 beta and TNF-alpha induced by LPS or
Aβ in the microglia (Capiralla et al., 2012; Zhong et al., 2012).
Further studies showed that the powerful neuroprotective effect
of resveratrol has also been confirmed in neurodegenerative
disorders, such as Parkinson’s disease, Alzheimer’s disease
(Albani et al., 2009), and in traumatic brain injury (Ates et al.,
2007; Zhang et al., 2015).
Prozorovski et al. (2008) found that the treatment of
neural progenitor cells (NPCs) with resveratrol mimicked
oxidizing conditions and increased differentiation of NPCs
toward astrocytes through a mechanism that requires Sirt1
(Prozorovski et al., 2008). Indeed subtle alterations of the redox
state, found in different brain pathologies, regulate the fate of
mouse NPCs through SIRT1. Mild oxidation or direct activation
of SIRT1 suppressed proliferation of NPCs and directed their
differentiation toward the astroglial lineage at the expense of the
neuronal lineage, whereas reducing conditions had the opposite
effect. Under oxidative conditions in vitro and in vivo, Sirt1 was
upregulated in NPCs, bound to the transcription factor Hes1
and subsequently inhibited pro-neuronal Mash1. In response
to brain injury, NPCs differentiate preferentially into astrocytes
rather than neurons. Excessive astrocyte expansion, known
as astrogliosis, can prevent growth of neurons and interfere
with proper damage repair. Therefore, the ability to direct
differentiation of NPCs may be useful in protecting the brain
against inflammatory diseases, such as multiple sclerosis, which
involve astrogliosis (Prozorovski et al., 2008).
Indeed resveratrol was shown to affect the activity of SIRT1
in vitro on depending to the nature of the substrate for
deacetylation (Baur and Sinclair, 2006). It has been reported
that the SIRT1 agonist resveratrol protects C. elegans neurons
expressing a fragment of the Huntington disease-associated
protein huntingtin and mammalian neurons from mutant
polyglutamine cytotoxicity in a HdhQ111 knock-inmousemodel
of Huntington disease (Dali-Youcef et al., 2007).
Moreover, resveratrol had no effect on the binding of
NF-κB proteins to the DNA, but it blocked the TNF-induced
translocation of p65 subunit of NF-κB and reporter gene
transcription. Similarly, the activation of c-Jun N-terminal
kinases (JNK) and its upstream MAPK are inhibited by
resveratrol, which may explain the mechanism of suppression of
AP-1 by resveratrol (Rahman et al., 2006).
Recently Zhang et al. (2015) investigated the potential role
of resveratrol in attenuating hypoxia-induced neurotoxicity via
its anti-inflammatory actions through in vitro models of the
BV-2 microglial cell line and primary microglia. The authors
found that resveratrol significantly inhibited hypoxia-induced
microglial activation and reduced subsequent release of pro-
inflammatory factors. In addition, resveratrol inhibited the
hypoxia-induced degradation of I kappa B-alpha (IκB-alpha) and
phosphorylation of p65 NF-κB protein. Importantly, treating
primary cortical neurons with conditioned medium (CM)
from hypoxia-stimulated microglia induced neuronal apoptosis,
which was reversed by CM co-treated with resveratrol. Taken
together, the results of this study suggest that resveratrol exerts
neuroprotection against hypoxia-induced neurotoxicity through
its anti-inflammatory effects in microglia. These effects were
mediated, at least in part, by suppressing the activation of NF-κB,
extracellular-signal-regulated kinases (ERK), and JNK/MAPK
signaling pathways (Zhang et al., 2015).
Although several studies reported an efficacy of these
compounds in animal model and in vitro, few plant-
based products have been assessed in methodologically
adequate human trials (Kennedy and Wightman, 2011),
and clinical experiments have often failed to demonstrate
any convincing therapeutic potency of these compounds
(Berger et al., 2012).
DIETARY PHYTOCHEMICALS ON
COGNITIVE PERFORMANCE IN HUMAN
STUDIES
Accumulated data strongly suggest that phytochemicals
from fruits, vegetables, herbs, and spices may exert relevant
immunomodulatory and/or anti-inflammatory activities in the
context of brain aging. The benefits of these substances for the
cognitive health of older adults have been reported in several
studies (Davinelli et al., 2015). In a recent review Shukitt-Hale
(2012) highlighted the potential benefits of blueberries as a
compound to impact age-related changes in neuronal aging.
Additionally, Devore et al. (2012) shown that greater self-
reported intakes of blueberries and strawberries were associated
with slower rates of cognitive decline. Although several evidences
point toward the beneficial effects of these substances, limitations
of these researches include the use of correlational data as well as
the lack of assessment of the bioavailability of these polyphenolic
compounds from diets (Rowland et al., 2000).
Commenges et al. (2000) demonstrated that the intake of
flavonoids in 1367 subjects over 65 years old was inversely
associated with the risk of dementia at a 5-years follow-up.
Recently Small et al. (2014) conducted a double-blind, placebo-
controlled clinical trial using a pill-based nutraceutical (NT-
020) that contained blueberry, carnosine, green tea, vitamin
D3, and Biovin to evaluate the impact on changes in cognitive
functioning. One hundred and five cognitively intact adults aged
65–85 years of age were randomized to receive NT-020 (n =
52) or a placebo (n = 53). Participants were tested with a
battery of cognitive performance tests that were classified into
six broad domains (episodic memory, processing speed, verbal
ability, working memory, executive functioning, and complex
speed) at baseline and 2 months later. The results indicated that
persons taking NT-020 improved significantly on two measures
of processing speed across the 2-month test period compared to
persons on the placebo whose performance did not change. The
authors concluded that the results were promising and suggest
the potential for interventions like these to improve the cognitive
health of older adults (Small et al., 2014).
Indeed these results have been confirmed by recent evidence
by Rabassa et al. (2015). In the context of the Invecchiare in
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Chianti (InCHIANTI), a cohort study with 3 years of follow-up,
the authors assessed the total urinary polyphenol (TUP) and the
total dietary polyphenol (TDP) concentrations in 652 individuals
without dementia aged 65 and older, and assessed cognition
using the Mini-Mental State Examination (MMSE) and Trail-
Making Test (TMT) at baseline and after 3 years of follow-up.
Higher TUP levels were associated with lower risk of substantial
cognitive decline on the MMSE and on the TMT-A, in a logistic
regression model adjusted for baseline cognitive score and
potential confounding factors. These findings showed that high
concentrations of polyphenols were associated with lower risk of
substantial cognitive decline in an older population studied over
a 3-year period, suggesting a protective effect against cognitive
impairment (Rabassa et al., 2015).
In a prospective study conducted among Japanese Americans
living in the King County of Washington, Dai et al. (2006) found
that frequent drinking of fruit and vegetable juices was associated
with a substantially decreased risk of Alzheimer’s disease, with
an inverse association stronger after adjustments for potential
confounding factors, and evident in all strata of selected variables.
These findings suggest that fruit and vegetable juices may play an
important role in delaying the onset of Alzheimer’s disease (Dai
et al., 2006).
Krikorian et al. (2010a,b) investigated the effects of daily
consumption of wild blueberry juice in a sample of nine older
adults with early memory changes. At 12 weeks, improved paired
associate learning and word list recall were observed. In addition,
there were trends suggesting reduced depressive symptoms and
lower glucose levels. Instead, twelve older adults with memory
decline but not dementia were enrolled in a randomized,
placebo-controlled, double blind trial with Concord grape juice
supplementation for 12 weeks (Butchart et al., 2011). The authors
observed significant improvement in ameasure of verbal learning
and non-significant enhancement of verbal and spatial recall.
There was no appreciable effect of the intervention on depressive
symptoms and no effect on weight or waist circumference. Then
these findings suggested that supplementation with Concord
grape juice may enhance cognitive function for older adults with
early memory decline.
In a more recent study (Devore et al., 2012), performed on
16,010 women aged ≥70 years, greater intakes of blueberries
and strawberries were associated with slower rates of cognitive
decline after adjusting for multiple potential confounders. Berry
intake appeared to delay cognitive aging by up to 2.5 years.
Additionally, in further supporting evidence, greater intakes of
anthocyanidins and total flavonoids were associated with slower
rates of cognitive decline in elder women (Devore et al., 2012).
On the other hand Butchart et al. (2011) investigated the
same issue but with control for possible confounding factors as
prior intelligence quotient (IQ). In a cross-sectional survey of
1091 men and women born in 1936, in which IQ was measured
at age 11 years, at the age of 70 years, participants carried
out various neuropsychological tests and completed a Food
Frequency Questionnaire. Total fruit, citrus fruits, apple, and tea
intakes were initially found to be associated with better scores in
a variety of cognitive tests, but the associations were no longer
statistically significant after adjusting for confounding factors,
including childhood IQ, not supporting a role for flavonoids in
the prevention of cognitive decline in later life (Butchart et al.,
2011).
However, in all of these studies, no specific information on
long-term dietary habits was available, while, long-term diet is
likely to be most relevant for cognitive decline (Devore et al.,
2012).
An epidemiological study (Ringman et al., 2012) suggested
that curcumin, as one of the most prevalent nutritional
and medicinal compounds used by the Indian population, is
responsible for the reduced (4.4-fold) prevalence of AD in India
compared to United States.
As seen above, although there are many experimental in
vitro and in vivo evidence of the efficacy of curcumin in the
prevention of neurodegeneration, at present very few human
studies have been performed, which have shown some utility of
this compound.
Ringman et al. (2012) performed a 24-week randomized,
double blind, placebo-controlled study of curcumin with an
open-label extension to 48 weeks. Thirty-six persons with mild-
to-moderate AD were randomized to receive placebo, 2 g/day, or
4 g/day of oral curcumin for 24 weeks. For weeks 24 through
48, subjects that were receiving curcumin continued with the
same dose, while subjects previously receiving placebo were
randomized in a 1:1 ratio to 2 g/day or 4 g/day. At the end of
the study no differences were found between treatment groups
in clinical or biomarker efficacy measures (Ringman et al., 2012).
Indeed Cox et al. (2015) in a randomized, double blind,
placebo-controlled trial examined the acute (1 and 3 h after a
single dose), chronic (4 weeks), and acute-on-chronic (1 and 3 h
after single dose following chronic treatment) effects of solid lipid
curcumin formulation (400mg) on cognitive function, mood and
blood biomarkers in 60 healthy adults aged 60–85. One hour after
administration curcumin significantly improved performance
on sustained attention and working memory tasks, compared
with placebo. Working memory and mood (general fatigue and
change in state calmness, contentedness and fatigue induced by
psychological stress) were significantly better following chronic
treatment. A significant acute-on-chronic treatment effect on
alertness and contentedness was also observed (Cox et al.,
2015).
All together these results highlight the need for further
investigation on the potential cognitive benefits of curcumin,
especially in elderly, and the importance of the dose and method
of administration.
Although the plant-derived polyphenol resveratrol has been
shown to increase memory performance in primates, also for this
compound interventional studies in older humans are lacking.
In a study by Kennedy et al. (2010) the effects of oral
resveratrol on cognitive performance and localized cerebral
blood flow variables in healthy human adults were assessed.
In this very interesting randomized, double blind, placebo-
controlled, crossover study, 22 healthy adults received
placebo and 2 doses (250 and 500 mg) of trans-resveratrol
in counterbalanced order on separate days. After a 45-min
resting absorption period, the participants performed a selection
of cognitive tasks that activate the frontal cortex for an additional
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36 min. Cerebral blood flow and hemodynamic, as indexed
by concentration changes in oxygenated and deoxygenated
hemoglobin, were assessed in the frontal cortex throughout
the post-treatment period with the use of near-infrared
spectroscopy. The presence of resveratrol and its conjugates
in plasma was confirmed by HPLC after the same doses in a
separate cohort (n = 9). Resveratrol administration resulted in
dose-dependent increases in cerebral blood flow during task
performance. There was also an increase in deoxyhaemoglobin
after both doses of resveratrol, which suggested enhanced
oxygen extraction that became apparent toward the end of the
45-min absorption phase and was sustained throughout task
performance. Cognitive function was not affected. Resveratrol
metabolites were present in plasma throughout the cognitive task
period, suggesting that single doses of orally administered
resveratrol can modulate cerebral blood flow variables
(Kennedy et al., 2010).
Witte et al. (2014) tested whether supplementation of
resveratrol would enhance memory performance in older
adults and addressed potential mechanisms underlying this
effect. Twenty-three healthy overweight older individuals treated
for 26 weeks with 200 mg/d resveratrol were compared
to 23 participants that received placebo. Before and after
the intervention/control period, subjects underwent memory
tasks and neuroimaging to assess volume, microstructure, and
functional connectivity (FC) of the hippocampus, a key region
implicated in memory functions. In addition, anthropometry,
glucose and lipid metabolism, inflammation, neurotrophic
factors, and vascular parameters were assayed. The authors
observed a significant effect of resveratrol on retention of
words over 30 min compared with placebo. In addition,
resveratrol led to significant increases in hippocampal FC, and
the increases in FC between the left posterior hippocampus
and the medial prefrontal cortex correlated with increases
in retention scores. Then these finding could offer the basis
for novel strategies to maintain brain health during aging
(Witte et al., 2014).
CONCLUSIONS
Despite the translational gap between basic and clinical
research, the current understanding of the molecular
interactions between phytochemicals, immune function,
and inflammatory response could help in designing effective
nutritional strategies to delay brain aging and improve cognitive
function.
Although, as described, many studies demonstrate the efficacy
in vitro and in vivo of phytochemicals (Table 1) in the prevention
and treatment of cognitive disorders, even few evidence of their
efficacy are available in humans, and especially still significant
differences in the protocols used, dosages and in the different way
of administration. Therefore, it seems that these results do not
allow to finalize, which is the real efficacy of these compounds to
prevent and to prevent and delay neuroinflammation associated
with aging. Further research, mainly conducted with randomized
controlled trials, should be performed in humans to determine
the real role that phytochemicals can play in the prevention and
treatment of neuroinflammaging.
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